FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W147682008> ?p ?o ?g. }

• W147682008 endingPage "755" @default.
• W147682008 startingPage "748" @default.
• W147682008 abstract "BACKGROUND AND PURPOSE Liquid N-butyl cyanoacrylate (n-BCA) use for the treatment of arteriovenous malformations (AVM) in the brain has become part of medical practice. However, no study has led to the Food and Drug Administration's approval of n-BCA for intravascular use. The purpose of this study was to verify the effectiveness and safety of an n-BCA/Tantalum Powder/Ethiodized Oil mixture, compared with conventional treatment (Trufill polyvinyl alcohol [PVA]) for preoperative embolization of cerebral AVM. METHODS Between October 15, 1996, and March 24, 1999, 104 patients at 13 centers were prospectively randomized to undergo embolization using an n-BCA/Tantalum Powder/Ethiodol mixture or Trufill PVA. The pre-embolization therapy goals were determined in terms of the number of pedicles to be embolized and the percent of nidus reduction expected. Embolization results were evaluated by a central laboratory. Subsequent surgical resection data were recorded. Safety evaluation data included recording device complications, procedure complications, and intracranial events/overall neurologic outcomes, which could be either device-related, procedure-related, or both. RESULTS The reduction of AVM dimensions (79.4% in the n-BCA group and 86.9% in the PVA group) and the mean number of vessels embolized (2.2 in the n-BCA group and 2.1 in the PVA group) was similar in the two groups. Coils were used more commonly with PVA embolization (P<.0001). No differences were detected in surgical resection time, number of patients who required transfusion, volume and number of transfusion units, or type and volume of fluid replacement. Glasgow Outcome Scale scores were not significantly different between the two groups before treatment, after embolization, or after resection. Two of 42 patients who underwent resection and had been treated with n-BCA experienced post-resection hematoma, compared with eight of 45 patients who underwent resection and had been treated with PVA (P<.05). CONCLUSION This prospective, randomized trial showed that n-BCA is equivalent to PVA as a preoperative embolic agent for treatment of cerebral AVM as determined by percent of nidus reduction and number of feeding pedicles embolized." @default.
• W147682008 created "2016-06-24" @default.
• W147682008 creator A5001528741 @default.
• W147682008 creator A5002154960 @default.
• W147682008 creator A5002536570 @default.
• W147682008 creator A5005275148 @default.
• W147682008 creator A5005406101 @default.
• W147682008 creator A5010423634 @default.
• W147682008 creator A5011089375 @default.
• W147682008 creator A5013737707 @default.
• W147682008 creator A5014273974 @default.
• W147682008 creator A5016851706 @default.
• W147682008 creator A5021864251 @default.
• W147682008 creator A5021952496 @default.
• W147682008 creator A5022788776 @default.
• W147682008 creator A5023667368 @default.
• W147682008 creator A5028127034 @default.
• W147682008 creator A5029136241 @default.
• W147682008 creator A5031100926 @default.
• W147682008 creator A5031746458 @default.
• W147682008 creator A5034501270 @default.
• W147682008 creator A5036639792 @default.
• W147682008 creator A5037177413 @default.
• W147682008 creator A5038359860 @default.
• W147682008 creator A5039991286 @default.
• W147682008 creator A5040966545 @default.
• W147682008 creator A5042201706 @default.
• W147682008 creator A5042955766 @default.
• W147682008 creator A5051620273 @default.
• W147682008 creator A5053009857 @default.
• W147682008 creator A5053151894 @default.
• W147682008 creator A5054602163 @default.
• W147682008 creator A5061718546 @default.
• W147682008 creator A5065718203 @default.
• W147682008 creator A5068524220 @default.
• W147682008 creator A5070338314 @default.
• W147682008 creator A5070510378 @default.
• W147682008 creator A5071743885 @default.
• W147682008 creator A5075643170 @default.
• W147682008 creator A5078077953 @default.
• W147682008 creator A5078921263 @default.
• W147682008 creator A5080923353 @default.
• W147682008 creator A5081369721 @default.
• W147682008 creator A5084576572 @default.
• W147682008 creator A5085533543 @default.
• W147682008 creator A5087950587 @default.
• W147682008 creator A5088305662 @default.
• W147682008 creator A5088522170 @default.
• W147682008 creator A5089307590 @default.
• W147682008 creator A5089312606 @default.
• W147682008 creator A5090403719 @default.
• W147682008 date "2002-05-28" @default.
• W147682008 modified "2023-09-27" @default.
• W147682008 title "N-butyl cyanoacrylate embolization of cerebral arteriovenous malformations: Results of a prospective, randomized, multi-center trial" @default.
• W147682008 cites W1487430287 @default.
• W147682008 cites W1830762985 @default.
• W147682008 cites W1849674401 @default.
• W147682008 cites W1855635155 @default.
• W147682008 cites W1968160840 @default.
• W147682008 cites W1976754668 @default.
• W147682008 cites W1979863485 @default.
• W147682008 cites W1985651239 @default.
• W147682008 cites W1999474289 @default.
• W147682008 cites W2013348842 @default.
• W147682008 cites W2051083511 @default.
• W147682008 cites W2060015278 @default.
• W147682008 cites W2065540596 @default.
• W147682008 cites W2066318161 @default.
• W147682008 cites W2075948731 @default.
• W147682008 cites W2080062044 @default.
• W147682008 cites W2082705355 @default.
• W147682008 cites W2092772469 @default.
• W147682008 cites W2094112956 @default.
• W147682008 cites W2103728369 @default.
• W147682008 cites W2113286838 @default.
• W147682008 cites W2124552328 @default.
• W147682008 cites W2126321126 @default.
• W147682008 cites W2181649944 @default.
• W147682008 cites W2342801915 @default.
• W147682008 cites W2343593248 @default.
• W147682008 cites W2403886496 @default.
• W147682008 cites W2412068986 @default.
• W147682008 cites W1988265014 @default.
• W147682008 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7974739" @default.
• W147682008 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12006271" @default.
• W147682008 hasPublicationYear "2002" @default.
• W147682008 type Work @default.
• W147682008 sameAs 147682008 @default.
• W147682008 citedByCount "48" @default.
• W147682008 countsByYear W1476820082012 @default.
• W147682008 countsByYear W1476820082013 @default.
• W147682008 countsByYear W1476820082015 @default.
• W147682008 countsByYear W1476820082016 @default.
• W147682008 countsByYear W1476820082017 @default.
• W147682008 countsByYear W1476820082018 @default.
• W147682008 countsByYear W1476820082019 @default.
• W147682008 countsByYear W1476820082020 @default.
• W147682008 countsByYear W1476820082021 @default.

• next